Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

North America Digital Genome Market Forecast 2021-2028

Published by Inkwood Research Product code 991380
Published Content info 138 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Digital Genome Market Forecast 2021-2028
Published: March 1, 2021 Content info: 138 Pages
Description

KEY FINDINGS

The North America digital genome market is evaluated to project a CAGR of 9.60%, during the forecast years of 2021 to 2028. The high prevalence of infectious diseases, dementia, Alzheimer's disease, and cancer, the growing incidence of monogenic conditions, and the rising adoption of advanced techniques by research facilities, are among the main factors attributed to the market growth of the region.

MARKET INSIGHTS

The North America digital genome market growth is determined by assessing Canada and the United States. The surging application area of personalized medicine across Canada, is anticipated to influence the country's digital genome market. Canada's future of medicine would be data-oriented and concentrated on generating personalized medicines for individual patients, on the basis of their molecular profile. In this regard, personalized medicine, also known as molecular medicine and precision medicine, would encourage a more detailed disease diagnosis. The approach is also expected to propel therapeutic inventions, predominantly in terms of treating infectious diseases, lung ailments, cancer, heart conditions, and neurological disorders.

Likewise, personalized medicine is significant, in terms of enhancing patient care with effective treatments, leading to controlling expenses. This factor is likely to become highly crucial as patient volume continues to surge, therefore resulting in the increased importance of the digital genome market, across Canada. The Canadian Genomics Cloud is an example of a digital genome database, which entails an integrated software ecosystem for the federated sharing, analysis, and management of clinical data and genome sequence. Therefore, these factors are projected to play a crucial role in propelling the country's digital genome market over the forecast period.

COMPETITIVE INSIGHTS

Some of the key firms operating in the market are, GenomeMe, Perkin Elmer Inc, Illumina Inc, Thermo Fisher Scientific Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 36136

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. INCREASING FUNDING BY THE MANUFACTURERS AND GOVERNMENTS IN GENOMICS
    • 3.1.2. ADVANCEMENTS IN TECHNOLOGY
    • 3.1.3. SURGING PREVALENCE OF CHRONIC DISEASES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. RISKS ASSOCIATED WITH SECURITY ISSUE OF DIGITAL GENOME
    • 3.2.2. LACK OF PROFESSIONALS WITH ADEQUATE KNOWLEDGE ABOUT THE GENOMIC TECHNOLOGY

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCES ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON DIGITAL GENOME MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT

  • 5.1. SEQUENCING AND ANALYZER INSTRUMENTS
  • 5.2. DNA/RNA ANALYSIS
  • 5.3. SEQUENCING AND ANALYSIS SOFTWARE
  • 5.4. SEQUENCING CHIPS
  • 5.5. SAMPLE PREP INSTRUMENTS

6. MARKET BY APPLICATION

  • 6.1. DIAGNOSTICS
  • 6.2. DRUG DISCOVERY
  • 6.3. ACADEMIC RESEARCH
  • 6.4. PERSONALIZED MEDICINE
  • 6.5. AGRICULTURAL
  • 6.6. OTHER APPLICATIONS

7. MARKET BY END-USER

  • 7.1. DIAGNOSTICS AND FORENSIC LABS
  • 7.2. ACADEMIC RESEARCH INSTITUTES
  • 7.3. HOSPITALS
  • 7.4. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. KEY GROWTH ENABLERS
    • 8.1.3. KEY CHALLENGES
    • 8.1.4. KEY PLAYERS
    • 8.1.5. COUNTRY ANALYSIS
      • 8.1.5.1. UNITED STATES
      • 8.1.5.2. CANADA

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGER & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 9.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 9.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 9.2. COMPANY PROFILE
    • 9.2.1. ABBOTT LABORATORIES
    • 9.2.2. AGILENT TECHNOLOGIES INC.
    • 9.2.3. BECTON, DICKINSON AND COMPANY (BD)
    • 9.2.4. BIOMERIEUX SA
    • 9.2.5. BIO-RAD LABORATORIES INC
    • 9.2.6. F. HOFFMANN-LA ROCHE
    • 9.2.7. ILLUMINA INC
    • 9.2.8. INSCRIPTA
    • 9.2.9. OXFORD NANOPORE TECHNOLOGIES LTD
    • 9.2.10. PACIFIC BIOSCIENCE
    • 9.2.11. PERKINELMER INC
    • 9.2.12. QIAGEN NV
    • 9.2.13. REGENERON PHARMACEUTICALS
    • 9.2.14. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - DIGITAL GENOME
  • TABLE 2: NORTH AMERICA DIGITAL GENOME MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: NORTH AMERICA DIGITAL GENOME MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: NORTH AMERICA DIGITAL GENOME MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA DIGITAL GENOME MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA DIGITAL GENOME MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA DIGITAL GENOME MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: NORTH AMERICA DIGITAL GENOME MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA DIGITAL GENOME MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: LEADING PLAYERS OPERATING IN NORTH AMERICA DIGITAL GENOME MARKET

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: KEY INVESTMENT INSIGHTS
  • FIGURE 5: NORTH AMERICA DIGITAL GENOME MARKET, BY PRODUCT, IN 2020
  • FIGURE 6: NORTH AMERICA DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 7: NORTH AMERICA DIGITAL GENOME MARKET, BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: NORTH AMERICA DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)
  • FIGURE 9: NORTH AMERICA DIGITAL GENOME MARKET, BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: NORTH AMERICA DIGITAL GENOME MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 11: NORTH AMERICA DIGITAL GENOME MARKET, BY APPLICATION, IN 2020
  • FIGURE 12: NORTH AMERICA DIGITAL GENOME MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA DIGITAL GENOME MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
  • FIGURE 14: NORTH AMERICA DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)
  • FIGURE 15: NORTH AMERICA DIGITAL GENOME MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
  • FIGURE 16: NORTH AMERICA DIGITAL GENOME MARKET, BY AGRICULTURAL, 2021-2028 (IN $ MILLION)
  • FIGURE 17: NORTH AMERICA DIGITAL GENOME MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 18: NORTH AMERICA DIGITAL GENOME MARKET, BY END-USER, IN 2020
  • FIGURE 19: NORTH AMERICA DIGITAL GENOME MARKET, BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
  • FIGURE 21: NORTH AMERICA DIGITAL GENOME MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
  • FIGURE 22: NORTH AMERICA DIGITAL GENOME MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
  • FIGURE 23: NORTH AMERICA DIGITAL GENOME MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 24: UNITED STATES DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 25: CANADA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
Back to Top